Authors: SIBILLE M BRESSON V JANIN A BOUTOUYRIE B REY J DURAND DV

Citation: M. Sibille et al., CRITICAL LIMITS TO DEFINE A LAB ADVERSE EVENT DURING PHASE-I STUDIES - A STUDY IN 1134 SUBJECTS, European Journal of Clinical Pharmacology, 52(2), 1997, pp. 81-86